Table 1 Demographics and characteristics for both cohorts.
From: Sex differences in methylphenidate-induced dopamine increases in ventral striatum
Mean (SD) | Mean (SD) | t, p | |
|---|---|---|---|
Cohort 1 (Oral 60 mg) | Males (n = 20) | Females (n = 12) | |
Age | 40.844 (12.135) | 44.983 (12.452) | 0.925, 0.362 |
BMI | 27.735 (3.250) | 27.608 (5.261) | −0.085, 0.933 |
Edu | 15.650 (1.531) | 15.75 (2.006) | 0.159, 0.875 |
% Caucasian | 50 | 33.33 | |
% African American | 45 | 50 | |
Cohort 2 (IV 0.5 mg/kg) | Males (n = 45) | Females (n = 18) | |
Age | 35.999 (8.273) | 30.672 (7.763) | −2.344, 0.022 |
BMI | 25.634 (2.855) | 24.513 (2.635) | −1.438, 0.156 |
Edu | 14.534 (2.291) | 14.833 (2.282) | 0.467, 0.642 |
% Caucasian | 35.56 | 11.11 | |
% African American | 51.11 | 44.44 |
